A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself. Researchers at The University of Texas MD Anderson Cancer Center report in iNature Communications/i. Patients with lung, ovarian, kidney or triple-negative breast cancers live longer if they have high levels of miR-200 expression, the researchers found. Subsequent experiments showed for the first time ...
via Medindia Health News More READ
No comments:
Post a Comment